Literature DB >> 30396264

Treadmill Exercise Improves Motor Function by Suppressing Purkinje Cell Loss in Parkinson Disease Rats.

Jae-Min Lee1, Tae-Woon Kim1, Sang-Seo Park1, Jin-Hee Han2, Mal-Soon Shin3, Baek-Vin Lim4, Sang-Hoon Kim1,5, Seung-Soo Baek5, Young Sam Cho6, Khae Hawn Kim7.   

Abstract

PURPOSE: Rotenone is the most widely used neurotoxin for the making Parkinson disease (PD) animal model. The neurodegenerative disorder PD shows symptoms, such as slowness of movements, tremor at resting, rigidity, disturbance of gait, and instability of posture. We investigated whether treadmill running improves motor ability using rotenone-caused PD rats. The effect of treadmill running on PD was also assessed in relation with apoptosis of cerebellar Purkinje cells.
METHODS: Treadmill running was applied to the rats in the exercise groups for 30 minutes once a day for 4 weeks, starting 4 weeks after birth. We used rota-rod test for the determination of motor coordination and balance. In this experiment, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining, immunohistochemistry for calbindin, glial fibrillary acidic protein (GFAP), Iba-1, and western blot analysis for Bax and Bcl-2 were performed.
RESULTS: Treadmill running enhanced motor balance and coordination by preventing the loss of Purkinje cells in the cerebellar vermis. Treadmill running suppressed PD-induced expression of GFAP-positive reactive astrocytes and Iba-1-positive microglia, showing that treadmill running suppressed reactive astrogliosis and microglia activation. Treadmill running suppressed TUNEL-positive cell number and Bax expression and enhanced Bcl-2 expression, demonstrating that treadmill running inhibited the progress of apoptosis in the cerebellum of rotenone-induced PD rats.
CONCLUSION: Treadmill running improved motor ability of the rotenone-induced PD rats by inhibiting apoptosis in the cerebellum. Apoptosis suppressing effect of treadmill running on rotenone-induced PD was achieved via suppression of reactive astrocyte and inhibition of microglial activation.

Entities:  

Keywords:  Apoptosis; Motor coordination; Parkinson disease; Rotenone, Cerebellum; Treadmill exercise

Year:  2018        PMID: 30396264      PMCID: PMC6234730          DOI: 10.5213/inj.1836226.113

Source DB:  PubMed          Journal:  Int Neurourol J        ISSN: 2093-4777            Impact factor:   2.835


• HIGHLIGHTS

- Parkinson disease is a neurodegenerative disorder showing slowness of movements, tremor at resting, rigidity, disturbance of gait, and instability of posture. - Treadmill running improved motor ability of the rotenone-induced Parkinson disease rats by inhibiting apoptosis in the cerebellum. - Apoptosis suppressing effect of treadmill running on rotenone-induced Parkinson disease was achieved via suppression of reactive astrocyte and inhibition of microglial activation.

INTRODUCTION

The neurodegenerative disorder Parkinson disease (PD) shows symptoms, such as tremor, bradykinesia, rigidity, and postural instability (motor symptoms) as well as depression, apathy, sleep disorders, and erectile dysfunction (nonmotor symptoms) [1,2]. Neurotoxin-based models of PD elucidate the underlying mechanisms of the dopaminergic neuronal cell death [3]. Rotenone is a potent mitochondrial complex I inhibitor, and then it is the most widely used neurotoxin to make animal model of PD. Intravenous or subcutaneous injection of rotenone decreased the survival rate of rats, and in their surviving rats, immunoreactivity of the striatal tyrosine hydroxylase was decreased [4]. If the calcium-binding protein, calbindin D-28k (calbindin), in the Purkinje cells of cerebellum was deleted, different alterations in the cellular constituents and behaviors were occurred [5]. Long-term activation of cerebellar Purkinje cells was correlated with dopaminergic neuronal degeneration [6]. Inflammation is an important pathogenesis factor causing age-associated neurodegenerative disorders, including PD [7]. Purkinje cells can be detected by immunohistochemistry for calbindin, and decreased number of the calbindin-positive Purkinje cells was observed in the cerebellum of autistic rats [8]. Astrocyte-associated pathogenesis causes neurodegenerative diseases, for example, PD, Alzheimer disease, Huntington disease, and amyotrophic lateral sclerosis [9]. In response to PD or ischemia, reactive astrogliosis appears as a hallmark of these diseases [10-12]. Iba1 protein is an ionized calcium binding adaptor molecule 1, and the expression of Iba1 was localized to macrophages and microglia [13]. Iba1 is a key molecule for ruffling of membrane and the phagocytosis of macrophages and microglia [14]. Microglia acts as a key initiator for rotenone-caused dopaminergic neuronal degeneration [15]. Activation of microglia has been suggested as the underlying mechanism of dopaminergic neuronal loss in the PD [16,17]. Apoptosis of neurons plays a crucial role for the PD induction [18,19]. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining can detect DNA fragmentation, and apoptotic neuronal cell death is confirmed by this TUNEL staining [20-22]. Two molecules, known as Bax (pro-apoptotic molecule) and Bcl-2 (anti-apoptotic molecule), regulate the process of apoptotic cell death. During the apoptosis process, Bax is largely expressed and then promotes cell death, in contrast, Bcl-2 exerts a protective effect against cell death [20,21]. Exercise is known to facilitate functional recovery from various brain injuries, including PD, Alzheimer disease, ischemia, and epilepsy [17,20,21]. In this study, we investigated whether treadmill running improves motor ability using rotenonecaused PD rats. In addition, the effect of treadmill running on PD was also assessed in relation with apoptosis of cerebellar Purkinje cells.

MATERIALS AND METHODS

Animal Treatments

We purchased Sprague-Dawley male rats (80±10 g, 4 weeks in age) for this experiment. All animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Kyung Hee University (KHUASP[SE]-16-151), and performed in accordance with the National Institute of Health Council for the management and use of laboratory animals. The rats were randomly classified into four groups (n=10 for each group): control, treadmill exercise, rotenone-injection, rotenone-injection and treadmill exercise group. Rotenone (Sigma Chemical Co., St. Louis, MO, USA) was diluted in the dimethyl sulfoxide:polyethylene glycol (1:1) solution. For the rats in the rotenone-injection groups, 3 mg/kg rotenone was injected, one time per a day during 14 days.

Treadmill Running Protocol

Treadmill running was applied to the rats in the exercise groups during 30 minutes, once time per a day for 4 weeks, starting 4 weeks after birth. The exercise speed was running at 2 m/min during 5 minutes, at 3 m/min during 5 minutes, and then at 5 m/min for 20 minutes with no inclination.

Rota-Rod Test

To detect motor coordination and balance, rota-rod (Harvard Apparatus, Holliston, MA, USA) test was conducted, as the method described before [23,24]. Each rat was placed on the rotating rod (diameter, 4 cm). Through the preliminary experiments, each rat was accustomed to the device at the speed of 4 rpm. After the preliminary experiments, the test trial was applied to the rats with increased speed from 4 rpm to 20 rpm. The latency until falling from the rota-rod was automatically counted. The maximum time to fall was limited to 180 seconds.

Immunohistochemistry

Immunohistochemistry for calbindin, glial fibrillary acidic protein (GFAP), and Iba-1-positive cells in the cerebellar vermis was conducted, as the method described before [8,20]. The sections were treated with 0.05M phosphate-buffered saline (PBS) during 5 minutes, and washed three times by 0.05M PBS. Freefloating sections were treated with 3% H2O2 during 30 minutes, and then the sections were treated with blocking solution (1% bovine serum albumin and 10% horse serum in 0.05M PBS) during 2 hours under the laboratory temperature. After treating with mouse anti-calbinind-D-28K antibody (1:500; Sigma Chemical Co.), goat anti-GFAP antibody (1:500; Chemicon International Inc., Temecula, CA, USA), and rabbit anti-Iba-1 antibody (1:500; Abcam, Cambridge, Cambridgeshire, UK) during overnight, the biotinylated anti-mouse, anti-goat, and antirabbit IgG secondary antibodies (1:200; Vector Laboratories, Burlingame, CA, USA) were treated. Avidin-biotin-peroxidase complex (Vector Laboratories) was treated to the section during 1 hour under the laboratory temperature. Following treatment with 0.02% diaminobenzidine and 0.03% H2O2 in 50mM Tris-HCl (pH, 7.6) during 5 minutes, the sections were treated with PBS, and then mounted onto gelatin-coated slide. Permount (Fisher Scientific, Fair Lawn, NJ, USA) was used for the mounting of coverslips. By the Image-Pro Plus software (Media Cybernetics Inc., Silver Spring, MD, USA), we quantified the number of calbindinpositive Purkinje cells in the 1,000- ×400-μm field of the cerebellar vermis. By the quantitative fashion based on optical density, the density of GFAP-positive reactive astrocytes and Iba1-positive microglia was assessed.

TUNEL Staining

By an In Situ Cell Death Detection Kit (Roche, Mannheim, Germany), TUNEL staining was processed, as the method described before [20,21]. After treating with ethanol-acetic acid (2:1), the sections were treated with proteinase K (100 μg/mL), treated with 3% H2O2, permeabilized with 0.5% Triton X-100, and then treated with the TUNEL reaction mixture. The sections were visualized by the label fluorescein-dUTP to the 39- end of DNA fragments. The fluorescent mounting medium (DakoCytomation, Carpinteria, CA, USA) was used for the mounting of coverslips. By the Image-Pro Plus software (Media Cybernetics Inc.), the number of TUNEL-positive cells in a field of 100 μm ×100 μm of the cerebellar vermis was counted.

Western Blot Analysis

For the detection of Bax and Bcl-2 expression, we used Western blotting, as the method described before [20,21]. After separating 40-µg protein on sodium dodecyl sulfate-polyacrylamide gels, protein was transferred onto a nitrocellulose membrane (Schleicher & Schuell GmbH, Dassel, Germany). For the primary antibodies, we used mouse anti-actin antibody (1:2,000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), mouse anti-Bax antibody (1:1,000; Santa Cruz Biotechnology), and mouse antiBcl-2 antibody (1:1,000 Santa Cruz Biotechnology). As the secondary antibodies, we used mouse horseradish peroxidase-conjugated antibody (1:2,000; Santa Cruz Biotechnology) for actin, Bax, and Bcl-2. We used enhanced chemiluminescence detection system (Amersham Pharmacia Biotechnology GmbH, Freiburg, Germany) for the band detection. By Image-Pro Plus software (Media Cybernetics Inc.), the detected bands were densitometrically analyzed.

Results Analysis

For the statistical analysis, 1-way analysis of variance with the Duncan post hoc test was performed. IBM SPSS Statistics ver. 22.0 (IBM Co., Armonk, NY, USA) was used for statistical analysis. Mean±standard error of the mean were presented for the expression of results, and P<0.05 was determined as a statistical significance.

RESULTS

Latency of Rota-Rod Test

Fig. 1 shows the latency of the rota-rod test. Our results showed that rotenone injection shortened the latency to fall (P<0.05), meanwhile, treadmill running lengthened the latency to fall of the rotenone-induced PD rats (P<0.05).
Fig. 1.

Treadmill exercise alleviates motor dysfunction after rotenone in the rota-rod test. A, control group; B, treadmill exercise group; C, rotenone-injection group; D, rotenone-injection and treadmill exercise group. *P<0.05 compared with the control group. # P<0.05 compared with the rotenone-injection group.

Purkinje Cells in Cerebellar Vermis

Fig. 2 is photomicrographs representing calbindin-positive Purkinje cells in the cerebellar vermis. Our results showed that rotenone injection suppressed the number of Purkinje cells in the cerebellar vermis (P<0.05), meanwhile, treadmill running increased this Purkinje cell number in the rotenone-induced PD rats (P<0.05).
Fig. 2.

Effect of treadmill exercise on Purkinje cells in the cerebellar vermis. Upper panel: Photomicrographs of calbindin immunostaining. The scale bar represents 1,000 μm (upper left), 200 μm (upper right), and 40 μm (lower). Lower panel: The number of calbindin-positive Purkinje cells in each group. A, control group; B, treadmill exercise group; C, rotenone-injection group; D, rotenone-injection and treadmill exercise group. *P<0.05 compared with the control group. # P<0.05 compared with the rotenone-injection group.

Reactive Astrocytes in Cerebellar Vermis

Fig. 3 is photomicrographs representing GFAP-positive reactive astrocytes in the cerebellar vermis. Our results showed that rotenone injection increased reactive astrocyte expression in the molecular and granular layers of cerebellar vermis (P<0.05), meanwhile, treadmill running inhibited this reactive astrocyte expression in the rotenone-induced PD rats (P<0.05).
Fig. 3.

Effect of treadmill exercise on reactive astrocyte in the cerebellar vermis. Upper panel: Photomicrographs of glial fibrillary acidic protein (GFAP) immunostaining. The scale bar represents 40 μm. Lower panel: The optical density of GFAP-positive cells in each group. A, control group; B, treadmill exercise group; C, rotenone-injection group; D, rotenone-injection and treadmill exercise group. *P<0.05 compared with the control group. # P<0.05 compared with the rotenone-injection group.

Microglia in Cerebellar Vermis

Fig. 4 is photomicrographs representing Iba-1-positive microglia in the cerebellar vermis. Our results showed that rotenone injection increased the expression of microglia in the molecular and granular layers of cerebellar vermis (P<0.05), meanwhile, treadmill running inhibited this microglia expression in the rotenone-induced PD rats (P<0.05).
Fig. 4.

Effect of treadmill exercise on microglia in the cerebellar vermis. Upper panel: Photomicrographs of Iba-1 immunostaining. The scale bar represents 40 μm. Lower panel: The optical density of Iba-1-positive cells in each group. A, control group; B, treadmill exercise group; C, rotenone-injection group; D, rotenone-injection and treadmill exercise group. *P<0.05 compared with the control group. # P<0.05 compared with the rotenone-injection group.

TUNEL-Positive Cells in Cerebellar Vermis

Fig. 5 is photomicrographs representing TUNEL-positive cells in the cerebellar vermis. Our results showed that rotenone injection enhanced the number of TUNEL-positive cells in the cerebellar vermis (P<0.05), meanwhile, treadmill running suppressed this TUNEL-positive cell number in the rotenone-induced PD rats (P<0.05).
Fig. 5.

Effect of treadmill exercise on terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)-positive cells in the cerebellar vermis. Upper panel: Photomicrographs of TUNEL immunostaining. The scale bar represents 10 μm. Upper panel: The number of TUNEL-positive cells in each group. A, control group; B, treadmill exercise group; C, rotenone-injection group; D, rotenone-injection and treadmill exercise group. *P<0.05 compared with the control group. # P<0.05 compared with the rotenone-injection group.

Bax and Bcl-2 Expressions in Cerebellum

Fig. 6 is the relative expression representing Bax and Bcl-2 in the cerebellum. Our results showed that rotenone injection increased the expression of Bax (P<0.05) and suppressed the expression of Bcl-2 in the cerebellum (P<0.05), meanwhile, treadmill running inhibited this Bax expression (P<0.05) and increased this Bcl-2 expression (P<0.05) in the rotenone-induced PD rats (P<0.05).
Fig. 6.

Effect of treadmill exercise on the expressions of Bax and Bcl-2 in the cerebellum. Upper panel: Representative Bax and Bcl-2 expressions. Middle panel: Relative optical density of Bax in each group. Lower panel: Relative optical density of Bcl-2 in each group. A, control group; B, treadmill exercise group; C, rotenone-injection group; D, rotenone-injection and treadmill exercise group. *P <0.05 compared with the control group. # P<0.05 compared with the rotenone-injection group.

DISCUSSION

Rotenone-induced PD rats showed decreased locomotor activity and delayed movement initiation time [4]. Rigidity, tremor, gait disturbance with non-motor symptom are caused by pathological changes of the cerebellum in PD [2]. Parameshwaran et al. [25] suggested that rotenone injection reduced the latency to fall that was determined by rota-rod test. Rotenone-induced PD rats showed disturbed motor balance and coordination in the rota-rod test, and loss of dopaminergic neurons and fibers in the nigrostriatum was observed [23]. Treadmill running improved motor balance and coordination by suppression of Purkinje cell loss in the cerebellar vermis of the autistic rats made by valproic acid [8]. Treadmill running preserved dopaminergic neurons and fibers and inhibited formation of Lewy bodies in the nigrostriatum, and then improved motor ability in the rotenone-induced PD rats [23]. In our study, rotenone injection suppressed Purkinje cell number in the cerebellar vermis. Rotenone injection also lessened the latency of the rota-rod test, suggested that rotenone impaired motor balance and coordination. In contrast, treadmill running improved this motor ability by inhibiting Purkinje cell loss in the cerebellar vermis. Reactive astrocytes or functional activation of astrocytes was abundantly appeared in traumatic, ischemic, and Parkinson’s animal models [11]. Loss of Purkinje cells in the cerebellar vermis has close relation with the reactive astrogliosis. Reactive astrogliosis is a response of astrocytes to brain injury, and GFAP is a marker of reactive astrocytes [8,20]. In the rotenone-induced PD rats, excessive microglial activation appeared in the striatum and substantia nigra [16]. Immunorectivity to Iba1 protein represents microglia, and Iba1 regulates the function of activated microglia [13]. Microglial activation is the main pathologic event for loss of dopaminergic neurons in the PD mice [17]. The memory enhancing effect of treadmill running may be due to the exercise-mediated inhibition of reactive astrocytes and microglia [8,17]. In our study, the expression of GFAP-positive reactive astrocytes and Iba-1-positive microglia in the cerebellar vermis of rotenone-induced PD rats was increased, demonstrating that rotenone injection induced reactive astrogliosis and microglia activation. In contrast, treadmill running suppressed PD-induced expression of GFAP-positive reactive astrocytes and Iba1-positive microglia, showing that treadmill exercise suppressed reactive astrogliosis and microglia activation. TUNEL-positive cells indicate DNA fragmentation, which represents apoptosis, and then decrease of TUNEL-positive cell number indicates inhibition of apoptosis [20,21]. Increase of pro-apoptotic Bax expression promotes apoptosis, in contrast, increase of antiapoptotic Bcl-2 expression inhibits apoptosis [20,21]. Apoptosis pathways in the Parkinson’s disease include signaling by Bcl-2 family proteins [19]. Bax up-regulation and Bcl-2 down-regulation in the SK-N-SH cells were appeared in the rotenone-induced apoptosis [26]. Enhanced Bax expression and suppressed Bcl-2 expression were occurred in the brain of PD animals [18,27]. Treadmill running inhibited Bax expression and increased Bcl-2 expression in the cerebellum of depressive rats [21]. In our study, TUNEL-positive cell number and Bax expression were enhanced and Bcl-2 expression was inhibited in the cerebellum of rotenone-induced PD rats. Our present results reveled that rotenone injection facilitated the progress of apoptosis in the cerebellum. In contrast, treadmill running suppressed these TUNEL-positive cell number and Bax expression and enhanced Bcl-2 expression, demonstrating that treadmill running inhibited the progress of apoptosis in the cerebellum of rotenone-induced PD rats. Presently, treadmill running improved motor ability in the rotenone-induced PD rats by inhibiting apoptosis in the cerebellum. Apoptosis suppressing effect of treadmill running on rotenone-induced PD was achieved via suppression of reactive astrocyte and inhibition of microglial activation. According to our results, exercise can be considered as a treatment modality for the patients with PD.
  27 in total

1.  Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone.

Authors:  Sheila M Fleming; Chunni Zhu; Pierre-Olivier Fernagut; Arpesh Mehta; Cheryl D DiCarlo; Ronald L Seaman; Marie-Françoise Chesselet
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

2.  Asiaticoside: attenuation of neurotoxicity induced by MPTP in a rat model of Parkinsonism via maintaining redox balance and up-regulating the ratio of Bcl-2/Bax.

Authors:  Chang-Liang Xu; Qi-Zhi Wang; Ling-Mei Sun; Xiu-Min Li; Ji-Min Deng; Lu-Fan Li; Jin Zhang; Rong Xu; Shi-Ping Ma
Journal:  Pharmacol Biochem Behav       Date:  2011-10-06       Impact factor: 3.533

Review 3.  Reactive astrocytes as potential manipulation targets in novel cell replacement therapy of Parkinson's disease.

Authors:  Liang-Wei Chen; Kin-Lam Yung; Ying-Shing Chan
Journal:  Curr Drug Targets       Date:  2005-11       Impact factor: 3.465

4.  Protection by an antioxidant of rotenone-induced neuromotor decline, reactive oxygen species generation and cellular stress in mouse brain.

Authors:  Kodeeswaran Parameshwaran; Michael H Irwin; Kosta Steliou; Carl A Pinkert
Journal:  Pharmacol Biochem Behav       Date:  2012-02-17       Impact factor: 3.533

5.  Effects of heat shock protein 72 (Hsp72) on evolution of astrocyte activation following stroke in the mouse.

Authors:  George E Barreto; Robin E White; Lijun Xu; Curtis J Palm; Rona G Giffard
Journal:  Exp Neurol       Date:  2012-08-20       Impact factor: 5.330

6.  Microglia-specific localisation of a novel calcium binding protein, Iba1.

Authors:  D Ito; Y Imai; K Ohsawa; K Nakajima; Y Fukuuchi; S Kohsaka
Journal:  Brain Res Mol Brain Res       Date:  1998-06-01

Review 7.  Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps.

Authors:  Oren A Levy; Cristina Malagelada; Lloyd A Greene
Journal:  Apoptosis       Date:  2009-04       Impact factor: 4.677

8.  Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease.

Authors:  Kuppusamy Tamilselvam; Nady Braidy; Thamilarasan Manivasagam; Musthafa Mohamed Essa; Nagarajan Rajendra Prasad; Subburayan Karthikeyan; Arokyasamy Justin Thenmozhi; Subash Selvaraju; Gilles J Guillemin
Journal:  Oxid Med Cell Longev       Date:  2013-09-24       Impact factor: 6.543

9.  Treadmill exercise improves motor and memory functions in cerebral palsy rats through activation of PI3K-Akt pathway.

Authors:  Sun-Young Jung; Dae-Young Kim
Journal:  J Exerc Rehabil       Date:  2017-04-30

Review 10.  The cerebellum in Parkinson's disease.

Authors:  Tao Wu; Mark Hallett
Journal:  Brain       Date:  2013-02-11       Impact factor: 13.501

View more
  7 in total

1.  Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulated in Exercise in a Mouse Model of Parkinson's Disease.

Authors:  Weifang Tong; Kunshan Zhang; Hongkai Yao; Lixi Li; Yong Hu; Jingxing Zhang; Yunping Song; Qiang Guan; Siguang Li; Yi E Sun; Lingjing Jin
Journal:  Front Aging Neurosci       Date:  2022-06-23       Impact factor: 5.702

2.  Understanding of Neurological Diseases.

Authors:  Chang-Ju Kim
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

3.  Up to Date on Astrocytes.

Authors:  Jin Wook Kim
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

Review 4.  Physical Activity and Brain Health.

Authors:  Carlo Maria Di Liegro; Gabriella Schiera; Patrizia Proia; Italia Di Liegro
Journal:  Genes (Basel)       Date:  2019-09-17       Impact factor: 4.096

Review 5.  Basic neurourology.

Authors:  Kwang Taek Kim; Hyun-Kyung Chang; Chang-Hee Kim; Kyung Jin Chung; Suzana Brown; Su Jin Kim; Khae-Hawn Kim
Journal:  J Exerc Rehabil       Date:  2019-12-31

6.  Microglial Activation Mediates Noradrenergic Locus Coeruleus Neurodegeneration via Complement Receptor 3 in a Rotenone-Induced Parkinson's Disease Mouse Model.

Authors:  Lu Jing; Liyan Hou; Dongdong Zhang; Sheng Li; Zhengzheng Ruan; Xiaomeng Zhang; Jau-Shyong Hong; Qingshan Wang
Journal:  J Inflamm Res       Date:  2021-04-09

Review 7.  Therapeutic Potential of Ursolic Acid in Cancer and Diabetic Neuropathy Diseases.

Authors:  Manzar Alam; Sabeeha Ali; Sarfraz Ahmed; Abdelbaset Mohamed Elasbali; Mohd Adnan; Asimul Islam; Md Imtaiyaz Hassan; Dharmendra Kumar Yadav
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.